Toby Schonfeld
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Toby Schonfeld has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Bruce Gordon
University of Nebraska Medical Center
2 shared publicationsJoseph S. Brown
University of Nebraska at Omaha
2 shared publicationsN. Jean Amoura
University of Nebraska Medical Center
2 shared publicationsDeborah Boucher-Payne
Clarkson College, Omaha, NE, USA
1 shared publicationElizabeth A. Stevens
1 shared publicationJames Anderson
University of Nebraska Medical Center
1 shared publication
Latest Publications
- 18 November 2014
- Published by Springer Nature in Journal of Religion and Health
- Vol. 55 (1) , 85-96
Incorporating Spirituality into Health Sciences Education
- 18 November 2014
- Published by Springer Nature in Journal of Religion and Health
- Vol. 55 (1) , 85-96
Incorporating Spirituality into Health Sciences Education
- 18 May 2013
- Published by Springer Nature in Theoretical Medicine and Bioethics
- Vol. 34 (3) , 189-206
The perils of protection: vulnerability and women in clinical research
Subpart B of 45 Code of Federal Regulations Part 46 (CFR) identifies the criteria according to which research involving pregnant women, human fetuses, and neonates can be conducted ethically in the United States. As such, pregnant women and fetuses fall into a category requiring “additional protections,” often referred to as “vulnerable populations.” The CFR does not define vulnerability, but merely gives examples of vulnerable groups by pointing to different categories of potential research subjects needing additional protections. In this paper, I assess critically the role of this categorization of pregnant women involved in research as “vulnerable,” both as separate entities and in combination with the fetuses they carry. In particular, I do three things: (1) demonstrate that pregnant women qua pregnancy are either not “vulnerable” according to any meaningful definition of that term or that such vulnerability is irrelevant to her status as a research participant; (2) argue that while a fetus may be vulnerable in terms of dependency, this categorization does not equate to the vulnerability of the pregnant woman; and (3) suggest that any vulnerability that appends to women is precisely the result of federal regulations and dubious public perceptions about pregnant women. I conclude by demonstrating how this erroneous characterization of pregnant women as “vulnerable” and its associated protections have not only impeded vital research for pregnant women and their fetuses, but have also negatively affected the inclusion of all women in clinical research.
- 18 May 2013
- Published by Springer Nature in Theoretical Medicine and Bioethics
- Vol. 34 (3) , 189-206
The perils of protection: vulnerability and women in clinical research
Subpart B of 45 Code of Federal Regulations Part 46 (CFR) identifies the criteria according to which research involving pregnant women, human fetuses, and neonates can be conducted ethically in the United States. As such, pregnant women and fetuses fall into a category requiring “additional protections,” often referred to as “vulnerable populations.” The CFR does not define vulnerability, but merely gives examples of vulnerable groups by pointing to different categories of potential research subjects needing additional protections. In this paper, I assess critically the role of this categorization of pregnant women involved in research as “vulnerable,” both as separate entities and in combination with the fetuses they carry. In particular, I do three things: (1) demonstrate that pregnant women qua pregnancy are either not “vulnerable” according to any meaningful definition of that term or that such vulnerability is irrelevant to her status as a research participant; (2) argue that while a fetus may be vulnerable in terms of dependency, this categorization does not equate to the vulnerability of the pregnant woman; and (3) suggest that any vulnerability that appends to women is precisely the result of federal regulations and dubious public perceptions about pregnant women. I conclude by demonstrating how this erroneous characterization of pregnant women as “vulnerable” and its associated protections have not only impeded vital research for pregnant women and their fetuses, but have also negatively affected the inclusion of all women in clinical research.
- 2 November 2011
- Published by Taylor & Francis in The American Journal of Bioethics
- Vol. 11 (11) , 31-38
“You Don't Know Me, But …”: Access to Patient Data and Subject Recruitment in Human Subjects Research
- 2 November 2011
- Published by Taylor & Francis in The American Journal of Bioethics
- Vol. 11 (11) , 31-38
“You Don't Know Me, But …”: Access to Patient Data and Subject Recruitment in Human Subjects Research
- 25 August 2011
- Published by SAGE Publications in American Journal of Hospice and Palliative Medicine®
- Vol. 29 (4) , 260-267
Assessing Challenges in End-of-Life Conversations With Elderly Patients With Multiple Morbidities
Introduction: This study reports on physicians' experiences in conducting end-of-life conversations with elderly patients who suffered from multiple co-morbidities (MCM). Our hypothesis was that both the lack of prognostic certainty and the lack of good communication tools contributed to physicians' discomfort with conducting EOL conversations with patients and families of patients with these conditions especially when compared with patients and families of patients who had a single, clear terminal diagnosis (e.g. pancreatic cancer). Methods: Focus group questions were semi-structured and explored three general themes: (1) differences between having an end-of-life conversation with patients/families with MCM versus those with a single, terminal diagnosis; (2) timing of the end-of-life conversation; and (3) approaches to the end-of-life conversation. Results: Three themes emerged: (1) It is more difficult for them to have EOL conversations with patients with MCM and their families, as opposed to conversations with families and patients who have a clear, terminal diagnosis. (2) In deciding when to raise the subject of EOL care, participants reported that they rely on a number of physical and/or social signs to prompt these discussions. Yet a major reason for the difficulty that providers face in initiating these discussions with MCM patients and families is that there is a lack of a clear threshold or prompting event. (3) Participants mentioned three types of approaches to initiating EOL conversations: (a) direct approach, (b) indirect approach, (c) collaborative approach. Conclusion: Prognostic indicies and communication scripts may better prepare physicians to facilitate end-of-life conversations with MCM patients/families.
- 25 August 2011
- Published by SAGE Publications in American Journal of Hospice and Palliative Medicine®
- Vol. 29 (4) , 260-267
Assessing Challenges in End-of-Life Conversations With Elderly Patients With Multiple Morbidities
Introduction: This study reports on physicians' experiences in conducting end-of-life conversations with elderly patients who suffered from multiple co-morbidities (MCM). Our hypothesis was that both the lack of prognostic certainty and the lack of good communication tools contributed to physicians' discomfort with conducting EOL conversations with patients and families of patients with these conditions especially when compared with patients and families of patients who had a single, clear terminal diagnosis (e.g. pancreatic cancer). Methods: Focus group questions were semi-structured and explored three general themes: (1) differences between having an end-of-life conversation with patients/families with MCM versus those with a single, terminal diagnosis; (2) timing of the end-of-life conversation; and (3) approaches to the end-of-life conversation. Results: Three themes emerged: (1) It is more difficult for them to have EOL conversations with patients with MCM and their families, as opposed to conversations with families and patients who have a clear, terminal diagnosis. (2) In deciding when to raise the subject of EOL care, participants reported that they rely on a number of physical and/or social signs to prompt these discussions. Yet a major reason for the difficulty that providers face in initiating these discussions with MCM patients and families is that there is a lack of a clear threshold or prompting event. (3) Participants mentioned three types of approaches to initiating EOL conversations: (a) direct approach, (b) indirect approach, (c) collaborative approach. Conclusion: Prognostic indicies and communication scripts may better prepare physicians to facilitate end-of-life conversations with MCM patients/families.
- 7 April 2011
- Published by Taylor & Francis in The American Journal of Bioethics
- Vol. 11 (4) , 18-20
Dropout by Design: Advance Planning for Research Participant Noncompliance
- 7 April 2011
- Published by Taylor & Francis in The American Journal of Bioethics
- Vol. 11 (4) , 18-20
Dropout by Design: Advance Planning for Research Participant Noncompliance
- 26 June 2009
- Vol. 31 (3) , 17-9
Data-sharing dilemmas: allowing pharmaceutical company access to research data.
- 26 June 2009
- Vol. 31 (3) , 17-9
Data-sharing dilemmas: allowing pharmaceutical company access to research data.